Favorable response to subcutaneous administration of infliximab in rats with experimental colitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

423

HTML

2162

Tables (1-4)

136

Sum=2721

Nov 21, 2005 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 21, 2005; 11(43): 6843-6847
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6843

Table 2 Percentage of bowel area without active inflammation in treated and untreated groups of animals (mean±SD)

Group	Percentage of mucosa without active inflammation	P value
1 (Infliximab 5)	99.55±0.19	0.049
2 (Infliximab 10)	95.43±5.15	0.088
3 (Infliximab 15)	73.98±39.29	0.705
4 (Untreated)	60.00±37.18

Citation: Triantafillidis JK, Papalois AE, Parasi A, Anagnostakis E, Burnazos S, Gikas A, Merikas EG, Douzinas E, Karagianni M, Sotiriou H. Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastroenterol 2005; 11(43): 6843-6847
URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6843.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i43.6843